The fields of pharmacology and pharmaceutical sciences converge to advance our understanding of how drugs interact with biological systems and how these agents can be engineered for optimal ...
Spinogenix received FDA authorization earlier this year for an Expanded Access Program, providing access to 200 ALS individuals ineligible for clinical trials in the United States. SPG302 has also ...
GlobalData on MSN
Dewpoint receives FDA orphan drug designation for DPTX3186
The ODD programme incentivises the development of medicines for conditions affecting fewer than 200,000 individuals in the US ...
The U.S. Food and Drug Administration (FDA) has granted orphan drug designation to DPTX3186, an investigational therapy being ...
Join us as experts discuss the future of cancer drug discovery, focusing on breakthroughs in genomics and targeted therapies.
Bayer AG is conducting a clinical study titled ‘A Single-blind, Placebo Controlled, Dose Escalation Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of BAY 3389934 ...
First orphan designation ever granted to a condensate-modulating therapeuticBuilds on recent IND opening for DPTX3186, a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback